![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 305, Issue 1, 40-47, April 2003
Department of Pharmaceutical Biology, Faculty of Pharmaceutical
Sciences, Kanazawa University, Kanazawa, Japan (H.T., Y.S., T.K., I.T.,
A.T.); Department of Molecular Biopharmaceutics, Faculty of
Pharmaceutical Sciences, Tokyo University of Science, Shinjuku-ku,
Tokyo, Japan (I.T.); and Core Research Evolutional Science and
Technology (CREST), Japan Science and Technology Corporation,
Kawaguchi, Japan (Y.S., I.T., A.T.)
The feasibility of using adenovirus-mediated human oligopeptide
transporter (hPEPT1) gene transfer to achieve peptide drug delivery to
the brain across the blood-brain barrier was tested by examining the
accumulation of model peptides in a rat brain endothelial cell line
(RBEC1) and rat brain after transduction with a recombinant adenovirus
encoding hPEPT1-enhanced yellow fluorescent protein fusion gene
(AdhPEPT1-EYFP). In vitro uptake of [3H]GlySar was
determined in RBEC1 transduced with AdhPEPT1-EYFP. In vivo, the
accumulation of cefadroxil in rat brain was evaluated after
transduction of AdhPEPT1-EYFP. At pH 6.0, the uptake of [3H]GlySar by RBEC1 transduced with AdhPEPT1-EYFP was
increased 4-fold compared with that of nontransduced cells. At pH 7.4, uptake of [3H]GlySar in AdhPEPT1-EYFP transduced RBEC1
was 1.5 times higher than that of nontransduced cells. Unlabeled
glycylsarcosine (10 mM) reduced the uptake of [3H]GlySar
to a level comparable with that of nontransduced cells. At 30 min after
intravenous administration of cefadroxil to rats transduced with
AdhPEPT1-EYFP at 3.2 × 109 plaque-forming
units/rat by an in situ brain perfusion method, the
brain-to-plasma concentration ratio (Kp) of cefadroxil was increased
about 2 times compared with that of nontransduced or AdGFP (control
vector)-transduced rats, although this was not statistically
significant. In contrast, Kp of [14C]inulin, a marker for
extracellular fluid space, remained unchanged after adenoviral
transduction. In conclusion, our results suggest that
adenovirus-mediated heterologous expression of hPEPT1 in vivo could be
a useful approach to deliver oligopeptides to the brain.